(54 days)
No
The description details a mechanical device for bone marrow aspiration with no mention of AI or ML components.
No
This device is a single-use needle intended for the aspiration/explant of bone marrow, which is a diagnostic or collection procedure, not a therapeutic treatment.
No
The device is described as a "single use disposable needle intended for the aspiration / explant of bone marrow." Its function is to collect bone marrow, not to analyze or interpret data for diagnostic purposes.
No
The device description clearly outlines a physical, single-use disposable needle with mechanical components (cannula, stylet, threaded insert, rotating spacer) for bone marrow aspiration. There is no mention of software as a component or the primary function of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "aspiration / explant of bone marrow through a piston syringe." This describes a procedure to collect a biological sample from the body.
- Device Description: The device is a needle designed for the physical collection of bone marrow. It facilitates the aspiration process.
- Lack of Diagnostic Function: There is no mention of the device being used to analyze the collected bone marrow or provide any diagnostic information about the patient's condition. IVD devices are specifically designed to perform tests on samples to diagnose diseases or conditions.
The device is a tool for sample collection, which is a step that might precede an in vitro diagnostic test, but the device itself does not perform the diagnostic test.
N/A
Intended Use / Indications for Use
The BONE MARROW MSC ASPIRATION KIT is intended for use for aspiration / explant of bone marrow through a piston syringe.
Product codes
KNW
Device Description
The BONE MARROW MSC ASPIRATION KIT is a single use disposable needle intended for the aspiration / explant of bone marrow.
The structure of BONE MARROW MSC ASPIRATION KIT device includes a cannula with a stylet inside, with a threaded insert and a rotating spacer that allow the precise retraction of the cannula to a determined length.
Once the cannula has been inserted and positioned, the stylet can be removed and a syringe is connected to execute the aspiration.
By manually rotating the rotating spacer, the cannula retracts, raising inside the bone marrow, in order to be able to perform aspiration / explant from fresh sites at different heights.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bone marrow
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
A program of design verification and validation testing was performed that includes the following:
- Biocompatibility; the following biocompatibility tests have been performed: Cytotoxicity, Sensitization, Irritation or intracutaneous reactivity, Material mediated pyrogenicity, Acute systemic toxicity
- Verification of Washing Process
- Packaging shelf life accelerated aging tests
- Performance/Functionality/Safety; the following tests have been performed: Needle retraction efficacy, Excursion of the Needle threaded insert, Maximum useful length of the needle cannula, Needle aspiration surface, Needle handle Grip during bone insertion procedures, Needle perforation capacity in the bone, Adequacy of the Needle Luer-Lock Connection, Quantity of bone marrow sample collected by the needle, Integrity of the aspiration syringe
- EO Sterilization Validation
Results of the evaluations demonstrate that the subject device met the safety and performance requirements as per its indication for use.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.1075 Gastroenterology-urology biopsy instrument.
(a)
Identification. A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification. (1) Class II (performance standards).(2) Class I for the biopsy forceps cover and the non-electric biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left, there is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square, the words "U.S. FOOD & DRUG" are written in blue, with the word "ADMINISTRATION" written in a smaller font size below.
January 11, 2021
Biopsybell s.r.l. % Maurizio Pantaleoni Senior Consultant Maytal Doo Kneza Milosa, 79 Belgrade, Serbia 11000 Serbia
Re: K203397
Trade/Device Name: BONE MARROW MSC ASPIRATION KIT Regulation Number: 21 CFR 876.1075 Regulation Name: Gastroenterology-Urology Biopsy Instrument Regulatory Class: Class II Product Code: KNW Dated: November 6, 2020 Received: November 18, 2020
Dear Maurizio Pantaleoni:
We have reviewed your Section 5100k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm_identifies_combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4. Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance)and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K203397
Device Name BONE MARROW MSC ASPIRATION KIT
Indications for Use (Describe)
The BONE MARROW MSC ASPIRATION KIT is intended for use for aspiration / explant of bone marrow through a piston syringe.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023 See PRA Statement below.
3
BIOPSYBELL SRL.
510(K) PREMARKET NOTIFICATION - K203397
-
- General Information
Submitter :
- General Information
Biopsybell srl is located at: Via A. Manuzio n.24 41037, Mirandola (MO) ITALY
Establishment Registration Number: 9617616
| Contact: | Maurizio Pantaleoni
Maytal Doo
Kneza Miloza 79
11000 Beograd (Serbia)
Tel. +381 11 3340700
Mob. +39 3484435155
Email: regulatory@maytal.eu |
|---------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact: | Carlo Ricca Prandi Bellini
Biopsybell srl
Via A. Manuzio n.24,
41037, Mirandola (MO), Italy
Telephone: +39 0535 27850
e-mail: qara@biopsybell.it |
| Summary Preparation Date: | January 06th, 2021 |
2. Name & Classification
| Device Name: | BONE MARROW MSC ASPIRATION KIT |
|---|---|
| Common Name: | Bone Marrow Biopsy Needle |
| Regulation Name: | Gastroenterology-urology biopsy instrument |
| Regulation Number: | 876.1075 |
| Product Code: | KNW |
| CLASS: | II |
3. Predicate Devices
The BONE MARROW MSC ASPIRATION KIT is substantially equivalent to the following devices:
| Applicant | Device name | 510(k) Number |
|---|---|---|
| RANFAC | Marrow Cellution Bone Marrow | |
| Aspiration Needle | K150563 | |
| BIOPSYBELL | Manual-bone-marrow-biopsy-needles, Semi- | |
| automatic-biopsy-needles, Automatic-biopsy-needles | K130616 |
4
BIOPSYBELL SRL.
510(K) PREMARKET NOTIFICATION - K203397
4. Indications for Use
The BONE MARROW MSC ASPIRATION KIT is intended for use for aspiration / explant of bone marrow through a piston syringe.
5. Device Description
The BONE MARROW MSC ASPIRATION KIT is a single use disposable needle intended for the aspiration / explant of bone marrow.
The structure of BONE MARROW MSC ASPIRATION KIT device includes a cannula with a stylet inside, with a threaded insert and a rotating spacer that allow the precise retraction of the cannula to a determined length.
Once the cannula has been inserted and positioned, the stylet can be removed and a syringe is connected to execute the aspiration.
By manually rotating the rotating spacer, the cannula retracts, raising inside the bone marrow, in order to be able to perform aspiration / explant from fresh sites at different heights.
| | Subject device | Predicate device
(K150563) | Reference device
(K130616) | Reference device
(K130616) |
|------------------|-----------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------|-------------------------------------------------------------|
| | | | Orion Explant | OSTEOBELL T |
| Device | BONE MARROW MSC
ASPIRATION KIT | Marrow Cellution
Bone Marrow
Aspiration Needle
(K150563) | ORION EXPLANT –
Needle for bone-
marrow explant
(K130616) | OSTEOBELL T - Needle
for bone-marrow biopsy
(K130616) |
| 510(K) number | - | | | |
| Applicant | BIOSPYBELL S.R.L. | RANFAC | BIOPSYBELL S.R.L. | BIOPSYBELL S.R.L. |
| Classification | | | | |
| Reg. Number | 876.1075 | 876.1075 | 876.1075 | 876.1075 |
| Product Code | KNW | KNW | KNW | KNW |
| Regulatory Class | II | II | II | II |
| Intended use | | | | |
| Intended use | The BONE MARROW
MSC ASPIRATION KIT is
intended for use for
aspiration / explant of
bone marrow through a
piston syringe. | The Marrow Cellution
Bone Marrow
Aspiration Needle is
intended for use for
aspiration
of bone marrow or
autologous blood
using a standard
piston syringe. | needle for bone-marrow
explant | needle for bone-marrow
biopsy |
6. Comparison with the predicate devices
5
BIOPSYBELL SRL. 510(K) PREMARKET NOTIFICATION - K203397
| | Subject device | Predicate device
(K150563) | Reference device
(K130616)
Orion Explant | Reference device
(K130616)
OSTEOBELL T |
|----------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|
| Mechanism of Action / Mode of Action | The mechanism of action is bone marrow aspiration / explant.
The needle is placed manually, then with a single puncture, is possible to collect bone marrow samples at different heights through the rotation of the rotating spacer. | The mechanism of action is bone marrow aspiration / explant.
The needle is placed manually, then with a single puncture, is possible to collect bone marrow samples at different heights through the rotation of the ring nut. | The mechanism of action is bone marrow aspiration / explant.
The needle is placed manually, then with a single puncture, is possible to collect bone marrow samples at different heights through the rotation of the ring nut. | The mechanism of action is bone marrow biopsy.
The needle is placed manually, then with a single puncture, is possible to collect bone marrow samples. |
| Design Features | | | | |
| Single Use Device | YES | YES | YES | YES |
| Dimensions of cannula (length / gauge) | 10 cm / 11 gauge
10 cm / 13 gauge | 9 cm / 11 gauge
11,4 cm / 11 gauge | 11-13-14-15 - gauge
Every gauge diameter is available in the following dimensions: 7, 9, 11, 13 cm | 7-8-9-11-13 gauge
Every gauge diameter is available in the following dimensions: 10, 15 cm |
| Materials | | | | |
| Cannula | AISI 304 stainless steel | Stainless steel | AISI 304 stainless steel | AISI 304 stainless steel |
| Syringe | Polycarbonate / ABS /
Silicone | N/A | N/A | N/A |
| Biocompatibility | | | | |
| Standard | Compliant to ISO 10993-1: | Compliant to ISO 10993-1: | Cytotoxicity
Intracutaneous
reactivity | Cytotoxicity
Intracutaneous
reactivity |
| Sterilization | | | | |
| Sterilization Method | Ethylene Oxide | Ethylene Oxide | Ethylene Oxide | Ethylene Oxide |
7. Performance Data
A program of design verification and validation testing was performed that includes the following:
- . Biocompatibility; the following biocompatibility tests have been performed:
- o Cytotoxicity
- o Sensitization
- Irritation or intracutaneous reactivity o
- o Material mediated pyrogenicity
- o Acute systemic toxicity
- . Verification of Washing Process
- . Packaging shelf life accelerated aging tests
- Performance/Functionality/Safety; the following tests have been performed:
- o Needle retraction efficacy
- Excursion of the Needle threaded insert O
- O Maximum useful length of the needle cannula
- o Needle aspiration surface
- o Needle handle Grip during bone insertion procedures
- Needle perforation capacity in the bone o
- o Adequacy of the Needle Luer-Lock Connection
6
- o Quantity of bone marrow sample collected by the needle
- o Integrity of the aspiration syringe
- EO Sterilization Validation
Results of the evaluations demonstrate that the subject device met the safety and performance requirements as per its indication for use.
8. Clinical data
N/A
9. Conclusions
In light of evidences summarized above and based on classification, intended use, technological characteristics and performance data, the subject device is as safe, as effective, and performs as well as the legally marketed predicate devices.